Track topics on Twitter Track topics that are important to you
Parc Eurasanté – Lille Métropole
885, avenue Eugène Avinée
Phone: +33 (0)3 20 16 40 00
Fax: +33 (0)3 20 16 40 01
GENFIT has completed patient enrolment in a Phase lla trial to investigate the efficacy and safety of elafibranor for the...Read More... The post GENFIT completes enrolment in Phase lla trial of elafi...
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Genfit’s elafibranor hits goal in phase 2 PBC trial .A phase 2 trial of Gen...
Genfit PBC data end of year http://www.genfit.com/wp-content/uploads/2018/08/2018.08.28-End-of-PBC-enrollment-PR-EN.pdf … $CBAY
#PressRelease GENFIT: Positive Phase 2 Results from Study of #Elafibranor in Primary Biliary Cholangitis https://www.genfit.com/wp-content/uploads/2018/12/2018.12.06-PR-PBC.pdf … #PBC #PrimaryBiliaryCholangitis #Autoimmunepic.twitter.com/d0nINSsU62
#PressRelease GENFIT: Positive Phase 2 Results from Study of #Elafibranor in Primary Biliary Cholangitis
Genfit announces plans for #IPO in the US $GNFT #NASH https://globenewswire.com/news-release/2018/11/19/1653382/0/en/GENFIT-ANNOUNCES-PLANS-TO-CONDUCT-REGISTERED-PUBLIC-OFFERING-IN-THE-UNITED-STATES.html …
Genfit announces plans for #IPO in the US $GNFT #NASH https://globenewswire.com/news-release/2018/11/19/1653382/0/en/GENFIT-ANNOUNCES-PLANS-TO-CONDUCT-REGISTERED-PUBLIC-OFFERING-IN-THE-UNITED-STAT...
GENFIT: Positive Phase 2 Results from Study of Elafibranor in Primary Biliary Cholangitis Elafibranor successfully meets primary endpoint with high statistical significance of p<...
GENFIT: Launch of a U.S. Phase 2 investigator-initiated study with nitazoxanide in patients with NASH-induced fibrosis $GNFT https://globenewswire.com/news-release/2018/12/03/1660476/0/en/GENFIT-Launch-of-a-U-S-Phase-2-investigator-initiated-study-with-ni
GENFIT: Launch of a U.S. Phase 2 investigator-initiated study with nitazoxanide in patients with NASH-induced fibrosis $GNFT https://globenewswire.com/news-release/2018/12/03/1660476/0/en/GENFIT-Lau...
GENFIT (Paris:ALGFT) is a biopharmaceutical company focused on the Discovery and Development of drug candidates in strategic therapeutic fields linked to cardiometabolic and neuro...
Bionest Partners Inc. provides strategy consulting services exclusively for the life science industries to help pharmaceutical, biopharmaceutical, diagnostics, biotechnology, and ...
We have published hundreds of GENFIT news stories on BioPortfolio along with dozens of GENFIT Clinical Trials and PubMed Articles about GENFIT for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of GENFIT Companies in our database. You can also find out about relevant GENFIT Drugs and Medications on this site too.
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...